Exact Mass: 582.1373

Exact Mass Matches: 582.1373

Found 22 metabolites which its exact mass value is equals to given mass value 582.1373, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Ivosidenib

2-(2-chlorophenyl)-2-{1-[1-(4-cyanopyridin-2-yl)-5-oxopyrrolidin-2-yl]-N-(5-fluoropyridin-3-yl)formamido}-N-(3,3-difluorocyclobutyl)acetamide

C28H22ClF3N6O3 (582.1394)


   

Bulbineloneside D

Bulbineloneside D

C29H26O13 (582.1373)


   

2'-O-Vanilloylvitexin

2- (4-Hydroxyphenyl) -5,7-dihydroxy-8- (2-O-vanilloyl-beta-D-glucopyranosyl) -4H-1-benzopyran-4-one

C29H26O13 (582.1373)


   

Perfoliatumin B

5,7,3,4-Tetrahydroxyflavone 6-C- (6"-O-p-methoxybenzoylglucoside)

C29H26O13 (582.1373)


   

4-O-Demethylknipholone-4-beta-D-glucopyranoside

4-O-Demethylknipholone-4-beta-D-glucopyranoside

C29H26O13 (582.1373)


   

quercetin 3-O-(6-O-phenylacetyl)-beta-D-glucopyranoside|thotneoside B

quercetin 3-O-(6-O-phenylacetyl)-beta-D-glucopyranoside|thotneoside B

C29H26O13 (582.1373)


   

M-4-demethylkhipholone-2-O-beta-D-glucopyranoside

M-4-demethylkhipholone-2-O-beta-D-glucopyranoside

C29H26O13 (582.1373)


   

2-O-Vanilloylvitexin

2-O-Vanilloylvitexin

C29H26O13 (582.1373)


   

AG-120

Ivosidenib

C28H22ClF3N6O3 (582.1394)


C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C137826 - Isocitrate Dehydrogenase Inhibitor > C168618 - IDH1 inhibitor L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent D000970 - Antineoplastic Agents D004791 - Enzyme Inhibitors IDH1 Inhibitor 8 (91) is isocitrate dehydrogenase 1 (IDH1) inhibitor. IDH1 Inhibitor 8 can be used for the research of cancer[1]. Ivosidenib (AG-120) is an orally active inhibitor of isocitrate dehydrogenase 1 mutant (mIDH1) enzyme, it exhibits profound d-2-hydroxyglutatrate (2-HG) lowering in vivo. Ivosidenib (AG-120) has the potential for AML therapy due to its acceptable safety profile and clinical activity[1].

   
   

(1S)​-1-​(Diphenylphosphino)​-​2-​[(1R)​-​1-​(diphenylphosphino)​ethyl]ferrocene

(1S)​-1-​(Diphenylphosphino)​-​2-​[(1R)​-​1-​(diphenylphosphino)​ethyl]ferrocene

C36H32FeP2 (582.1329)


   

4-O-demethylknipholone-4-O-beta-D-glucopyranoside

4-O-demethylknipholone-4-O-beta-D-glucopyranoside

C29H26O13 (582.1373)


An anthraquinone that is knipholone in which the O-methyl group is replaced by a beta-D-glucopyranosyl group. It is isolated from the roots of Bulbine frutescens and exhibits trypanocidal and antiplasmodial activities.

   

(R,S)-Ivosidenib

(R,S)-Ivosidenib

C28H22ClF3N6O3 (582.1394)


(R,S)-Ivosidenib ((R,S)-AG-120) is the less active enantiomer of Ivosidenib (AG-120)[1].

   

1-(3-acetyl-2,6-dihydroxy-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)-4,5-dihydroxy-2-methylanthracene-9,10-dione

1-(3-acetyl-2,6-dihydroxy-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)-4,5-dihydroxy-2-methylanthracene-9,10-dione

C29H26O13 (582.1373)


   

1-(3-acetyl-4,6-dihydroxy-2-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)-4,5-dihydroxy-2-methylanthracene-9,10-dione

1-(3-acetyl-4,6-dihydroxy-2-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)-4,5-dihydroxy-2-methylanthracene-9,10-dione

C29H26O13 (582.1373)


   

1-(3-acetyl-2,6-dihydroxy-4-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)-4,5-dihydroxy-2-methylanthracene-9,10-dione

1-(3-acetyl-2,6-dihydroxy-4-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)-4,5-dihydroxy-2-methylanthracene-9,10-dione

C29H26O13 (582.1373)


   

(2s,3r,4s,5s,6s)-2-[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-8-yl]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl 4-hydroxy-3-methoxybenzoate

(2s,3r,4s,5s,6s)-2-[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-8-yl]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl 4-hydroxy-3-methoxybenzoate

C29H26O13 (582.1373)


   

2''-o-vanilloylvitexin

2''-o-vanilloylvitexin

C29H26O13 (582.1373)


   

1-(3-acetyl-2,6-dihydroxy-4-{[(2s,3s,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)-4,5-dihydroxy-2-methylanthracene-9,10-dione

1-(3-acetyl-2,6-dihydroxy-4-{[(2s,3s,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)-4,5-dihydroxy-2-methylanthracene-9,10-dione

C29H26O13 (582.1373)


   

2-[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-8-yl]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl 4-hydroxy-3-methoxybenzoate

2-[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-8-yl]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl 4-hydroxy-3-methoxybenzoate

C29H26O13 (582.1373)


   

(2s,3r,4s,5s,6r)-2-[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-8-yl]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl 4-hydroxy-3-methoxybenzoate

(2s,3r,4s,5s,6r)-2-[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-8-yl]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl 4-hydroxy-3-methoxybenzoate

C29H26O13 (582.1373)


   

1-(3-acetyl-4,6-dihydroxy-2-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)-4,5-dihydroxy-2-methylanthracene-9,10-dione

1-(3-acetyl-4,6-dihydroxy-2-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)-4,5-dihydroxy-2-methylanthracene-9,10-dione

C29H26O13 (582.1373)